Supplements for Aging Over 60: What the Evidence Actually Shows

Walk into any pharmacy or health food store and the shelves dedicated to "healthy aging" supplements have multiplied dramatically over the past decade. For adults over 60, the supplement industry offers an almost overwhelming array of options, each promising to restore vitality, sharpen the mind, protect the heart, or slow the biological clock. The global dietary supplement market for older adults is projected to exceed $60 billion by 2030, yet the clinical evidence supporting most of these products remains far thinner than the marketing suggests. The gap between what people are buying and what rigorous science can actually confirm is one of the most consequential disconnects in modern preventive medicine.

This is not an argument against supplementation. Some compounds have accumulated genuinely compelling evidence, particularly for adults whose diets, sun exposure, or absorptive capacity may fall short of physiological requirements. Others occupy a more nuanced position: promising mechanistic data, early-phase human trials, and biological rationale that justify cautious interest without yet warranting universal recommendation. And some widely purchased products remain, after decades of study, largely unsupported by the kind of large-scale randomized evidence that should guide clinical decisions. Understanding which is which matters enormously for anyone trying to invest wisely in their own healthspan after 60.

Why the Biology of Aging After 60 Changes the Supplement Equation

The case for examining supplements through a longevity lens begins with a fundamental physiological reality: the body at 65 is not simply an older version of the body at 35. Beginning in the fifth decade and accelerating through the sixth and seventh, a cascade of biological changes alters how nutrients are absorbed, how hormones are synthesized, how muscles respond to protein, and how the immune system regulates inflammation. Each of these shifts creates specific nutritional vulnerabilities that supplementation might plausibly address.

Gastric acid production declines with age, a process called hypochlorhydria, which impairs the absorption of vitamin B12, calcium, iron, and zinc from food. The skin's capacity to synthesize vitamin D from ultraviolet light drops by roughly 50% between the ages of 20 and 70 [1]. Skeletal muscle becomes progressively less responsive to dietary protein, a phenomenon researchers call anabolic resistance, meaning older adults require more protein per kilogram of body weight than younger adults to achieve the same muscle protein synthesis response [2]. Meanwhile, low-grade chronic inflammation, often called inflammaging, creates a persistent metabolic drag that accelerates tissue damage across virtually every organ system [3].

These are not abstract concerns. Sarcopenia, the progressive loss of skeletal muscle mass and strength that begins around age 40 and accelerates after 60, affects an estimated 10 to 16% of community-dwelling older adults globally and is one of the strongest predictors of disability, falls, and mortality [4]. Cognitive decline, cardiovascular disease, and metabolic dysregulation compound the picture. The question is not whether nutritional biology changes after 60, but which interventions are supported by sufficient evidence to recommend, which deserve cautious optimism, and which should be treated with skepticism despite their popularity.

The body at 65 is not simply an older version of the body at 35: specific physiological shifts create nutritional vulnerabilities that targeted supplementation may plausibly address, but only when the evidence meets the biology.

Vitamin D and K2: The Bone-Vascular Axis

Vitamin D deficiency is among the most prevalent nutritional insufficiencies in adults over 60, with estimates suggesting that 40% or more of older Americans have circulating 25-hydroxyvitamin D levels below the threshold generally considered optimal for musculoskeletal health [1]. This matters because vitamin D functions less like a conventional vitamin and more like a steroid hormone, binding to receptors in nearly every tissue in the body, including muscle, immune cells, the brain, and the cardiovascular system. Its roles extend far beyond calcium absorption and bone mineralization.

The randomized trial evidence on vitamin D supplementation for older adults is more complicated than many clinicians once hoped. The landmark VITAL trial, which enrolled more than 25,000 adults over five years, found that supplementation with 2,000 IU daily did not significantly reduce the primary endpoints of cancer incidence or cardiovascular events in the overall population [5]. However, the picture is not entirely discouraging: post-hoc analyses from VITAL and other large trials suggest benefits in cancer mortality, autoimmune disease risk reduction, and musculoskeletal outcomes, particularly in individuals who were deficient at baseline [6].

The case for combining vitamin D with vitamin K2 (specifically the MK-7 form) has gained traction in the cardiovascular and bone health literature. Vitamin D increases intestinal calcium absorption, but without adequate vitamin K2, that calcium may deposit in arterial walls rather than bone matrix. K2 activates osteocalcin and matrix Gla protein, two proteins that shuttle calcium into bone and actively inhibit arterial calcification [7]. Population studies consistently associate higher K2 intake with lower rates of coronary artery calcification and cardiovascular mortality, though large interventional trials are still limited [8]. For older adults taking vitamin D supplements, adding K2 appears physiologically sensible and carries a favorable safety profile.

What the evidence supports is targeted repletion based on measured deficiency rather than blanket high-dose supplementation. Testing serum 25-hydroxyvitamin D levels and supplementing to achieve a level in the range of 40 to 60 ng/mL is a more defensible approach than assuming universal high-dose need. This is precisely the kind of individualized assessment that underpins a comprehensive longevity program, and it points toward why biomarker testing matters before reaching for the supplement bottle.

Omega-3 Fatty Acids: Cardiovascular Controversy and What Remains Standing

Few supplements have been studied as extensively or generated as much conflicting evidence as omega-3 fatty acids. The biological rationale is compelling: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the two marine-derived omega-3s found in fish oil, reduce serum triglycerides, modulate inflammatory signaling pathways, support neuronal membrane integrity, and appear to influence telomere length, one of the molecular markers of biological aging [9].

The cardiovascular evidence has undergone significant revision in recent years. Earlier meta-analyses of fish oil trials that showed neutral cardiovascular effects were largely conducted with doses of around 1 gram per day. The REDUCE-IT trial changed the conversation substantially: high-dose icosapentaenoic acid (EPA alone, at 4 grams daily) produced a 25% relative reduction in major adverse cardiovascular events in patients with established cardiovascular disease or diabetes and elevated triglycerides [10]. The STRENGTH trial, using a combined EPA/DHA formulation at the same dose, did not replicate this benefit, raising important questions about whether the effect is specific to pure EPA or was partly attributable to the mineral oil placebo used in REDUCE-IT [11]. The debate remains active, but the therapeutic case for high-dose EPA in high-risk patients is better supported than the general fish oil market would suggest.

For brain health, the picture is similarly nuanced. DHA is the predominant structural fatty acid in the cerebral cortex and retina, and observational data consistently link higher dietary omega-3 intake to lower rates of cognitive decline and dementia [9]. Interventional trials in cognitively normal or mildly impaired older adults have shown more modest effects, possibly because supplementation is most beneficial before significant neuronal loss has occurred. The takeaway for adults over 60 is that optimizing omega-3 status, ideally through both dietary sources (fatty fish two to three times weekly) and supplementation when intake is insufficient, represents a reasonable, low-risk strategy with meaningful biological support.

Magnesium: The Underappreciated Workhorse

Magnesium participates in more than 300 enzymatic reactions in the human body, including ATP synthesis, DNA repair, protein synthesis, and the regulation of muscle and nerve function. It is also one of the most commonly depleted minerals in the modern diet, with surveys suggesting that more than 45% of Americans fail to meet the recommended dietary intake, a proportion that increases with age due to reduced dietary intake, decreased intestinal absorption, and increased renal excretion [12].

The relevance to aging is substantial. Magnesium deficiency accelerates the hallmarks of aging at a cellular level, including increased oxidative stress, telomere shortening, impaired mitochondrial function, and the accumulation of DNA damage [12]. Clinically, low magnesium status is associated with increased risk of type 2 diabetes, hypertension, cardiovascular disease, osteoporosis, and depression, all conditions whose prevalence rises sharply after 60. A large meta-analysis of prospective studies found that each 100 mg per day increment in dietary magnesium intake was associated with a 19% lower risk of type 2 diabetes, a 22% lower risk of ischemic heart disease, and a 7% lower risk of stroke [13].

The form of magnesium matters for both absorption and clinical application. Magnesium oxide, the cheapest and most common supplement form, has poor bioavailability. Magnesium glycinate and magnesium threonate are better absorbed and are preferred for general repletion and cognitive support respectively. Magnesium threonate in particular has shown the ability to cross the blood-brain barrier and increase synaptic density in animal studies, with early human trials suggesting benefits for cognitive function and sleep quality [14]. For most adults over 60, ensuring adequate magnesium intake through diet and a moderate-dose supplement is one of the most cost-effective, evidence-supported steps available.

Creatine: Not Just for Athletes

Creatine monohydrate has long been associated with gym culture and athletic performance, which has obscured its potential as one of the most evidence-backed supplements for healthy aging. The biology is elegant: creatine, stored in muscle and brain tissue as phosphocreatine, serves as a rapid-access energy buffer, allowing cells to rapidly regenerate ATP during high-demand activities. Think of it as a reserve fuel cell that sits next to the main engine, ready to discharge instantly when power requirements spike. As muscle creatine stores decline with age, the capacity to perform brief, intense physical work diminishes, contributing to the functional decline characteristic of sarcopenia.

The clinical trial literature on creatine supplementation in older adults is unusually robust for a non-prescription compound. A 2017 meta-analysis of 22 randomized controlled trials found that creatine supplementation combined with resistance training produced significantly greater gains in lean muscle mass and upper and lower body strength in adults over 55 compared to resistance training alone [15]. Beyond muscle, emerging evidence supports creatine's role in cognitive performance: several randomized trials have demonstrated improvements in working memory, processing speed, and executive function in older adults supplementing with creatine [16]. The brain is an energetically demanding organ, consuming roughly 20% of the body's total energy budget despite accounting for only 2% of its mass, and creatine appears to support neural energy metabolism in ways that become increasingly relevant as mitochondrial efficiency declines with age.

Creatine's reputation as an athlete's supplement has long obscured its evidence base as one of the most rigorously studied compounds for preserving muscle mass and cognitive function in adults over 60.

The standard supplementation protocol for older adults is 3 to 5 grams of creatine monohydrate daily, without the loading phase that athletes sometimes use. The safety profile is excellent across decades of research, with no evidence of kidney harm in individuals with normal renal function at these doses. For older adults already engaged in resistance training, or those trying to build the capacity to do so, creatine represents a genuinely useful tool. Healthspan's Creatine + Protein Bundle addresses both the creatine and the protein anabolic resistance issue simultaneously, recognizing that these two interventions are most powerful in combination.

Protein Adequacy: The Foundation Everything Else Depends On

Before any discussion of specialized supplements can be meaningful, protein adequacy must be established. The recommended dietary allowance for protein in adults is 0.8 grams per kilogram of body weight per day, a figure that was derived from nitrogen balance studies designed to prevent deficiency, not to optimize muscle preservation or functional longevity in older adults. The evidence now strongly supports substantially higher targets for adults over 60. Most leading researchers in the field of muscle and aging recommend 1.2 to 1.6 grams of protein per kilogram of body weight per day for older adults, with some evidence supporting even higher intakes in those engaged in resistance training [2].

The protein quality matters as much as quantity. Leucine, an essential branched-chain amino acid, functions as the primary molecular trigger for muscle protein synthesis, activating the mTOR signaling pathway in a dose-dependent fashion. Animal-derived proteins (whey, eggs, meat, fish) generally have higher leucine content and better overall amino acid profiles than most plant proteins, though well-planned combinations of plant proteins can achieve comparable outcomes [2]. Whey protein, particularly consumed shortly after resistance exercise, consistently outperforms other protein sources in stimulating acute muscle protein synthesis in older adults. For those whose dietary protein falls short, a high-quality protein supplement like Healthspan's Alpha-Lactalbumin Protein provides a bioavailable, leucine-rich option that works in concert with exercise rather than replacing it.

NAD+ Precursors: The Mitochondrial Aging Story

Nicotinamide adenine dinucleotide, or NAD+, sits at the intersection of several of the most consequential biological processes in aging. It serves as an essential coenzyme in mitochondrial energy production, as a substrate for sirtuins (a family of proteins that regulate gene expression and DNA repair in response to metabolic stress), and as a cofactor for PARP enzymes that detect and repair DNA strand breaks. The critical problem is that NAD+ levels fall dramatically with age: human studies using mass spectrometry have documented declines of 40 to 60% between young adulthood and the seventh decade of life [17].

This decline has cascading consequences. As NAD+ falls, mitochondrial function deteriorates, DNA repair capacity diminishes, sirtuin activity drops, and the metabolic flexibility that characterizes younger physiology erodes. Animal studies using NAD+ precursors, primarily nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), have produced remarkable results: improved mitochondrial function, enhanced muscle endurance, better metabolic parameters, and in some cases extended lifespan [18]. These findings drove enormous enthusiasm and a wave of human trials.

The human data, while encouraging, requires more careful interpretation. Multiple randomized trials have confirmed that oral NR and NMN supplementation reliably raises NAD+ levels in human blood and tissues [19]. Whether this translates into meaningful clinical benefits remains an area of active investigation. A Phase 2 trial in healthy older adults found that NR supplementation improved several markers of metabolic health and reduced levels of circulating inflammatory cytokines [19]. Larger, longer trials with hard clinical endpoints are ongoing. The mechanistic rationale is sound, the safety profile is favorable, and the gap between animal and human evidence is narrowing. For adults over 60 interested in supporting mitochondrial health, NAD+ precursors represent one of the more scientifically credentialed emerging interventions, though they are not yet in the category of definitively proven therapies.

Urolithin A: Mitophagy and the Cellular Recycling System

Urolithin A represents a newer class of longevity-relevant compound that sits at the intersection of gut microbiome science and mitochondrial biology. It is a postbiotic, meaning it is produced not by the body itself or by direct dietary intake, but by the metabolism of ellagitannins (found in pomegranates, walnuts, and berries) by specific gut bacteria. The critical problem is that the majority of adults, estimated at 60 to 70%, lack the gut microbial composition needed to produce urolithin A efficiently, meaning that consuming pomegranates provides no benefit for most people unless the right bacteria are present [20].

Urolithin A's primary mechanism is the induction of mitophagy, the selective autophagy of damaged mitochondria. Think of mitophagy as the cellular equivalent of a quality control system on a factory floor: it identifies defective machinery and routes it for disassembly so its parts can be recycled and new, functional units built. As this process declines with age, damaged mitochondria accumulate, releasing reactive oxygen species and promoting the inflammatory signaling that characterizes inflammaging. By restoring mitophagy flux, urolithin A addresses one of the more fundamental drivers of age-related cellular dysfunction.

The human trial data is early but notable. A 2022 randomized controlled trial in older adults with low muscle endurance found that supplementation with 500 mg or 1,000 mg of urolithin A daily for four months produced significant improvements in muscle endurance compared to placebo, alongside favorable changes in mitochondrial gene expression and biomarkers of mitochondrial health [21]. This represents the first direct evidence in humans that pharmacological induction of mitophagy can improve a functional outcome relevant to aging. Larger trials are needed, but urolithin A is among the most scientifically interesting supplements to emerge in the longevity space in the past decade.

Collagen Peptides: Connective Tissue and Beyond

Collagen is the most abundant protein in the human body, forming the structural scaffold of skin, tendons, ligaments, cartilage, and bone. Its synthesis declines by approximately 1% per year from early adulthood, with more pronounced losses occurring after menopause in women due to the withdrawal of estrogen, which directly regulates collagen gene expression [22]. By the seventh decade, skin collagen density has fallen by roughly 30%, and the cumulative loss in joint cartilage and connective tissue contributes meaningfully to the musculoskeletal decline that characterizes aging.

Hydrolyzed collagen peptides, consumed orally, are absorbed as di- and tripeptides that appear to stimulate fibroblast activity and endogenous collagen synthesis. A 2019 randomized trial found that 15 grams of collagen peptides taken 60 minutes before exercise significantly increased collagen synthesis markers in connective tissue compared to placebo, suggesting that the combination of collagen supplementation and mechanical loading creates the optimal stimulus for tissue repair [23]. Skin-focused trials consistently show improvements in skin elasticity, hydration, and wrinkle depth with daily supplementation over 8 to 12 weeks [22]. The evidence for joint pain reduction is more variable but generally positive for specific collagen peptide formulations.

Supplements With a More Complicated Evidence Base

Several popular supplements marketed aggressively for healthy aging over 60 deserve more critical scrutiny than they typically receive in the wellness media. Resveratrol, the polyphenol found in red wine, generated enormous excitement following animal studies showing dramatic lifespan extension in model organisms. Human trials have been consistently disappointing: bioavailability is poor, effective doses are difficult to achieve through supplementation, and large randomized trials have failed to demonstrate meaningful benefits for cardiovascular disease or metabolic health in humans [24].

Coenzyme Q10 (CoQ10) is another widely purchased supplement with a more nuanced evidence picture than its market presence suggests. As a component of the mitochondrial electron transport chain and a lipid-soluble antioxidant, CoQ10 has clear biological relevance to aging, and plasma levels do decline with age. The evidence for benefit in heart failure patients is reasonably strong, with the Q-SYMBIO trial showing reduced cardiovascular mortality with CoQ10 supplementation [25]. For healthy older adults without heart failure, however, the evidence is considerably weaker. CoQ10 is a reasonable consideration for anyone taking statins (which reduce endogenous CoQ10 synthesis as a side effect of their mechanism of action), but it should not be treated as a universal anti-aging compound.